IDiyas

For the Inventor, By the Inventor

Tinton Falls, NJ, United States of America

David Keenan

USPTO Granted Patents = 11

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 35(Granted Patents)


Company Filing History:

goldMedal10 out of 59 
 
Angel Medical Systems Inc.
 patents
silverMedal1 out of 1 
 
Avertix Medical, Inc.
 patent

Years Active: 2012-2024

Loading Chart...
11 patents (USPTO):Explore Patents
1. 11980450 - Advanced cardiovascular monitoring system with normal, elevated, and high heartrate thresholds (2024-05-14),
2. 11426089 - Advanced cardiovascular monitoring system with normal, elevated, and high heartrate thresholds (2022-08-30),
3. 11357439 - Advanced cardiovascular monitoring system with personalized st-segment thresholds (2022-06-14),
4. 9486153 - Medical device system having an implanted medical device and an external device (2016-11-08),
5. 9326696 - Medical accessory proximity testing, detection, and alerting system (2016-05-03),
6. 8855782 - Medical accessory proximity testing, detection, and alerting system (2014-10-07),
7. 8805498 - Ischemia detection systems for paced-patients using beat-type dependent baseline datasets (2014-08-12),
8. 8676304 - Ischemia monitoring system for patients having periods of left bundle branch block (2014-03-18),
9. 8452404 - Ischemia detection systems for paced-patients having three different detection modes (2013-05-28),
10. 8275457 - Cardiac monitoring system for paced patients having paced and non-paced ischemia detection thresholds (2012-09-25),
11. 8170653 - Baseline processing for the detection of cardiac events (2012-05-01),

Title: Innovations in Cardiovascular Monitoring by David Keenan

Introduction

David Keenan is an accomplished inventor based in Tinton Falls, NJ (US), known for his significant contributions to the field of cardiovascular monitoring. With a total of 11 patents to his name, he has developed advanced systems that enhance the detection and management of heart-related conditions.

Latest Patents

One of his latest patents is an advanced cardiovascular monitoring system that features normal, elevated, and high heart rate thresholds. This innovative system is designed to detect acute coronary syndrome (ACS) events, arrhythmias, heart rate abnormalities, and medication-related issues such as non-compliance or ineffective dosages. The system comprises both implanted and external components that communicate with a physician's programmer and smart devices for real-time monitoring and alerting of medically relevant events. The processor within the system utilizes statistical threshold criteria based on a patient's data to provide accurate event detection. Cardiovascular conditions are tracked using histogram, trend, and summary information related to heart rate and cardiac features, including S-T segment measures of heartbeats. This technology allows for the identification of heartbeats with elevated rates, providing alerts for potential medication non-compliance and other abnormalities.

Career Highlights

Throughout his career, David Keenan has worked with notable companies in the medical technology sector, including Angel Medical Systems Inc. and Avertix Medical, Inc. His work has significantly impacted the development of devices that improve patient outcomes in cardiovascular health.

Collaborations

David has collaborated with several professionals in the field, including Michael Sasha John and David R. Fischell, contributing to the advancement of innovative medical technologies.

Conclusion

David Keenan's work in cardiovascular monitoring exemplifies the intersection of technology and healthcare, showcasing his commitment to improving patient care through innovation. His patents reflect a deep understanding of medical needs and the application of technology to address them effectively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…